[HTML][HTML] Alternative approaches to target Myc for cancer treatment
The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL,
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc …
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc …
[HTML][HTML] miRNAs reshape immunity and inflammatory responses in bacterial infection
X Zhou, X Li, M Wu - Signal transduction and targeted therapy, 2018 - nature.com
Pathogenic bacteria cause various infections worldwide, especially in immunocompromised
and other susceptible individuals, and are also associated with high infant mortality rates in …
and other susceptible individuals, and are also associated with high infant mortality rates in …
[HTML][HTML] Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
K-RAS is a highly relevant oncogene that is mutated in approximately 90% of pancreatic
cancers and 20–25% of lung adenocarcinomas. The aim of this work was to develop a new …
cancers and 20–25% of lung adenocarcinomas. The aim of this work was to develop a new …
[HTML][HTML] Selective and noncovalent targeting of RAS mutants for inhibition and degradation
Activating mutants of RAS are commonly found in human cancers, but to date selective
targeting of RAS in the clinic has been limited to KRAS (G12C) through covalent inhibitors …
targeting of RAS in the clinic has been limited to KRAS (G12C) through covalent inhibitors …
[HTML][HTML] Crosstalk between miRNAs and DNA Methylation in Cancer
M Saviana, P Le, L Micalo, D Del Valle-Morales… - Genes, 2023 - mdpi.com
miRNAs are some of the most well-characterized regulators of gene expression. Integral to
several physiological processes, their aberrant expression often drives the pathogenesis of …
several physiological processes, their aberrant expression often drives the pathogenesis of …
[HTML][HTML] Mammalian antiviral systems directed by small RNA
T Takahashi, SM Heaton, NF Parrish - PLoS pathogens, 2021 - journals.plos.org
There are strong incentives for human populations to develop antiviral systems. Similarly,
genomes that encode antiviral systems have had strong selective advantages. Protein …
genomes that encode antiviral systems have had strong selective advantages. Protein …
[HTML][HTML] Non-coding RNAs in cancer diagnosis and therapy: focus on lung cancer
Simple Summary Researchers have spent nearly two decades unraveling the roles of non-
coding RNAs in cancer biology. In recent years, deep transcriptomic profiling of tissue and …
coding RNAs in cancer biology. In recent years, deep transcriptomic profiling of tissue and …
[HTML][HTML] Actionability classification of variants of unknown significance correlates with functional effect
A Johnson, PKS Ng, M Kahle, J Castillo… - npj Precision …, 2023 - nature.com
Genomically-informed therapy requires consideration of the functional impact of genomic
alterations on protein expression and/or function. However, a substantial number of variants …
alterations on protein expression and/or function. However, a substantial number of variants …
MicroRNAs and cancer: a long story for short RNAs
A Drusco, CM Croce - Advances in cancer research, 2017 - Elsevier
More than six decades ago Watson and Crick published the chemical structure of DNA. This
discovery revolutionized our approach to medical science and opened new perspectives for …
discovery revolutionized our approach to medical science and opened new perspectives for …
[HTML][HTML] Overexpression of human BAG3P209L in mice causes restrictive cardiomyopathy
K Kimura, A Ooms, K Graf-Riesen… - Nature …, 2021 - nature.com
An amino acid exchange (P209L) in the HSPB8 binding site of the human co-chaperone
BAG3 gives rise to severe childhood cardiomyopathy. To phenocopy the disease in mice …
BAG3 gives rise to severe childhood cardiomyopathy. To phenocopy the disease in mice …